Cargando…

Longitudinal Study of Therapeutic Adherence in a Cystic Fibrosis Unit: Identifying Potential Factors Associated with Medication Possession Ratio

Cystic fibrosis (CF) is a genetic and multisystemic disease that requires a high therapeutic demand for its control. The aim of this study was to assess therapeutic adherence (TA) to different treatments to study possible clinical consequences and clinical factors influencing adherence. This is an a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Girón, Rosa Mª, Peláez, Adrián, Ibáñez, Amparo, Martínez-Besteiro, Elisa, Gómez-Punter, Rosa Mar, Martínez-Vergara, Adrián, Ancochea, Julio, Morell, Alberto
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687051/ https://www.ncbi.nlm.nih.gov/pubmed/36421281 http://dx.doi.org/10.3390/antibiotics11111637

Ejemplares similares

Treatment of Pulmonary Disease of Cystic Fibrosis: A Comprehensive Review
por: Girón Moreno, Rosa María, et al.
Publicado: (2021)

Long-term safety and efficacy of tobramycin in the management of cystic fibrosis
por: Vázquez-Espinosa, Emma, et al.
Publicado: (2015)

Role of C-reactive protein as a biomarker for prediction of the severity of pulmonary exacerbations in patients with cystic fibrosis
por: Girón-Moreno, Rosa Maria, et al.
Publicado: (2014)

Impact of the SARS-CoV-2 Virus Pandemic on Patients with Bronchiectasis: A Multicenter Study
por: Martínez-Vergara, Adrián, et al.
Publicado: (2022)

New evidence in severe pneumonia: imipenem/ cilastatin/relebactam
por: Girón, Rosa Mª, et al.
Publicado: (2022)

Temporal Changes on Pulmonary Artery Size on Computed Tomography in Adults With Cystic Fibrosis
por: Zorzo, Cristina, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic in mortality due to respiratory diseases: A comparative analysis of 2021 and 2020 vs 2019 in Spain
por: Soriano, Joan B, et al.
Publicado: (2023)

ABO blood group as a determinant of COVID-19 and Long COVID: An observational, longitudinal, large study
por: Soriano, Joan B., et al.
Publicado: (2023)

Medicine possession ratio as proxy for adherence to antiepileptic drugs: prevalence, associations, and cost implications
por: Jacobs, Karen, et al.
Publicado: (2016)

Genitourinary tract symptoms in patients admitted with COVID-19: Exploring changes in frequency by determinants and pandemic waves
por: Viegas Madrid, Vanessa, et al.
Publicado: (2023)

The Emergence of COVID-19 as a Cause of Death in 2020 and its Effect on Mortality by Diseases of the Respiratory System in Spain: Trends and Their Determinants Compared to 2019
por: Soriano, Joan B., et al.
Publicado: (2022)

Validation of a Spanish version of the Leicester Cough Questionnaire in cystic fibrosis
por: Muñoz, Gerard, et al.
Publicado: (2021)

Adherence in chronic hepatitis B: associations between medication possession ratio and adverse viral outcomes
por: Allard, Nicole L., et al.
Publicado: (2020)

Clinical impact of chronic obstructive pulmonary disease on non-cystic fibrosis bronchiectasis. A study on 1,790 patients from the Spanish Bronchiectasis Historical Registry
por: De la Rosa, David, et al.
Publicado: (2017)

Inhaled Dry Powder Antibiotics in Patients with Non-Cystic Fibrosis Bronchiectasis: Efficacy and Safety in a Real-Life Study
por: Martínez-García, Miguel Ángel, et al.
Publicado: (2020)

Phenotypic Clustering in Non-Cystic Fibrosis Bronchiectasis Patients: The Role of Eosinophils in Disease Severity
por: Wang, Xuejie, et al.
Publicado: (2021)

An upper and lower bound of the Medication Possession Ratio
por: Sperber, Christian M, et al.
Publicado: (2017)

MEntA Program Based on Motivational Interview to Improve Adherence to Treatment of Obstructive Sleep Apnea With Continuous Positive Airway Pressure (CPAP): A Randomized Controlled Trial
por: Rudilla, David, et al.
Publicado: (2021)

Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells
por: Lingner, Meike, et al.
Publicado: (2017)

Strategies to optimize treatment adherence in adolescent patients with cystic fibrosis
por: Bishay, Lara C, et al.
Publicado: (2016)

Adherence, reliability, and variability of home spirometry telemonitoring in cystic fibrosis
por: Beaufils, Fabien, et al.
Publicado: (2023)

Prevalence and factors associated with nontuberculous mycobacteria in non-cystic fibrosis bronchiectasis: a multicenter observational study
por: Máiz, L., et al.
Publicado: (2016)

Prevalence of Chronic Obstructive Pulmonary Disease in an Urban Area. Changes in COPD Ten Years on
por: García Castillo, Elena, et al.
Publicado: (2022)

Inositol possesses antifibrotic activity and mitigates pulmonary fibrosis
por: Li, Ji-Min, et al.
Publicado: (2023)

Promoting adherence to nebulized therapy in cystic fibrosis: poster development and a qualitative exploration of adherence
por: Jones, Stephen, et al.
Publicado: (2015)

Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate “normative adherence”
por: Hoo, Zhe Hui, et al.
Publicado: (2016)

Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study
por: Cho, Sung Joon, et al.
Publicado: (2022)

Patient knowledge and pulmonary medication adherence in adult patients with cystic fibrosis
por: Lin, Ann Hsu-An, et al.
Publicado: (2017)

Medication Possession Ratio Predicts Antiretroviral Regimens Persistence in Peru
por: Salinas, Jorge L., et al.
Publicado: (2013)

Antisense Oligonucleotide Therapeutics for Cystic Fibrosis: Recent Developments and Perspectives
por: Kim, Young Jin, et al.
Publicado: (2023)

Adherence to medication in adults with Cystic Fibrosis: An investigation using objective adherence data and the Theoretical Domains Framework
por: Arden, Madelynne A., et al.
Publicado: (2019)

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
por: Lumley, Elizabeth, et al.
Publicado: (2022)

Copper and Copper/Zinc Ratio in a Series of Cystic Fibrosis Patients
por: Escobedo-Monge, Marlene Fabiola, et al.
Publicado: (2020)

Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis
por: Kozma, Chris M, et al.
Publicado: (2013)

Measuring adherence to ARVs among HIV-positive adolescents in Cameroon: a comparative assessment of self-report and medication possession ratio methods
por: Bongfen, Mbuwir Charlotte, et al.
Publicado: (2021)

Mechanisms of the noxious inflammatory cycle in cystic fibrosis
por: Rottner, Mathilde, et al.
Publicado: (2009)

Motivational Interviewing for Adherence Problems in Cystic Fibrosis; Evaluation of Training Healthcare Professionals
por: Duff, Alistair James Aitken, et al.
Publicado: (2013)

Supporting medication adherence for adults with cystic fibrosis: a randomised feasibility study
por: Hind, Daniel, et al.
Publicado: (2019)

TREATMENT ADHERENCE AMONG CHILDREN AND ADOLESCENTS IN A CYSTIC FIBROSIS REFERENCE CENTER
por: Bonfim, Bianca Sampaio, et al.
Publicado: (2020)

Usefulness of the CONUT index upon hospital admission as a potential prognostic indicator of COVID-19 health outcomes
por: Bengelloun, Adrián K., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2apij2g9unpc0bgutbkdbudhon